11/26/2024
3:57 PM | Kyverna Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/26/2024
3:40 PM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:16 PM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:23 AM | Kyverna Therapeutics (Subject)
Westlake BioPartners Fund I, L.P. (Filed by)
| Form SC 13G | |
10/24/2024
5:02 AM | Aktar Mert (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2024
5:05 AM | Aktar Mert (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
7:00 AM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/10/2024
11:36 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Kyverna Therapeutics (Subject)
| Form SC 13G | |
09/18/2024
8:11 PM | Kyverna Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2024
8:15 PM | Biddle Warner Weston (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2024
8:16 PM | Kyverna Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
8:18 PM | Biddle Warner Weston (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:05 AM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:18 PM | Kyverna Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
3:11 PM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
3:11 PM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
5:12 AM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
5:56 PM | Kyverna Therapeutics (Issuer)
Walker Karen Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:33 PM | Jones Ryan Alexander (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
3:40 PM | Kyverna Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:13 PM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
5:56 PM | Kyverna Therapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:03 PM | Cohen Fred E (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:04 PM | Kyverna Therapeutics (Issuer)
Vida Ventures GP III, L.L.C. (Reporting)
Vida Ventures III, L.P. (Reporting)
Vida Ventures III-A, L.P. (Reporting)
Vida Ventures, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
4:35 PM | Harper Sean E (Reporting)
Kyverna Therapeutics (Issuer)
Westlake BioPartners Fund I, L.P. (Reporting)
Westlake BioPartners GP I, LLC (Reporting)
Westlake BioPartners Opportunity Fund I, L.P. (Reporting)
Westlake BioPartners Opportunity GP I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
4:20 PM | Bain Capital Life Sciences Opportunities III, LP (Filed by)
Kyverna Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
4:26 PM | Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
Bain Capital Life Sciences Opportunities III GP, LLC (Reporting)
Bain Capital Life Sciences Opportunities III, LP (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:48 PM | GILEAD SCIENCES, INC. (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
4:51 PM | Kyverna Therapeutics (Issuer)
Northpond Ventures III GP, LLC (Reporting)
Northpond Ventures III, LP (Reporting)
Rubin Michael P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:44 PM | Kyverna Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/08/2024
7:15 AM | Kyverna Therapeutics (Filer)
| Form CERT | |
02/07/2024
11:15 PM | Kyverna Therapeutics (Filer)
| Form EFFECT | |
02/08/2024
5:04 AM | Kyverna Therapeutics (Issuer)
Liapis Stephen Constantine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
5:10 AM | Kyverna Therapeutics (Issuer)
Liapis Stephen Constantine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:55 PM | Kyverna Therapeutics (Issuer)
Maag Peter (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:55 PM | Kyverna Therapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:56 PM | Jones Ryan Alexander (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:56 PM | Kyverna Therapeutics (Issuer)
Vida Ventures, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:57 PM | Kotzin Brian L. (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:57 PM | Chung James Bum (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:57 PM | Kyverna Therapeutics (Issuer)
Walker Karen Marie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Lock in this disruptor’s share price before 12/5 (Ad) Spencer Rascoff co-founded Zillow. Austin Allison sold his company to Zillow for $125M. Now they’ve joined forces to launch a venture transforming the $1.3T vacation home market – and the results are already turning heads.
This company is leading the co-ownership revolution, offering buyers a chance to own a fraction of a luxury vacation home instead of the entire thing. It’s a model that’s unlocked new demand and earned them over $100M in gross profits in four years. Don’t miss your chance to maximize your stake in this co-ownership revolution. |
02/07/2024
8:58 PM | Cohen Fred E (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:58 PM | CLARK IAN T (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:58 PM | Borie Dominique Christian (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:58 PM | Kyverna Therapeutics (Issuer)
SPIEGELMAN DANIEL K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:51 PM | Harper Sean E (Reporting)
Kyverna Therapeutics (Issuer)
Westlake BioPartners Fund I, L.P. (Reporting)
Westlake BioPartners GP I, LLC (Reporting)
Westlake BioPartners Opportunity Fund I, L.P. (Reporting)
Westlake BioPartners Opportunity GP I, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:23 PM | Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
Bain Capital Life Sciences Opportunities III GP, LLC (Reporting)
Bain Capital Life Sciences Opportunities III, LP (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
7:30 PM | Kyverna Therapeutics (Issuer)
Northpond Ventures III GP, LLC (Reporting)
Northpond Ventures III, LP (Reporting)
Rubin Michael P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
4:35 PM | GILEAD SCIENCES, INC. (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2024
5:10 AM | Kyverna Therapeutics (Filer)
| Form S-1/A | |
02/05/2024
3:01 PM | Kyverna Therapeutics (Filer)
| Form 8-A12B | |
01/31/2024
8:47 PM | Kyverna Therapeutics (Filer)
| Form S-1/A | |
01/16/2024
3:46 PM | Kyverna Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
Free KYTX Stock Alerts